HomeCoronary diseaseAcute coronary syndromes

Acute coronary syndromes

Visual Assessment for Non-Culprit Lesion Revascularization

There is evidence in favor of complete revascularization in the context of ST elevation MI with multivessel...

ESC 2020 | New European Guidelines on Non-ST-Segment Elevation Acute Coronary Syndromes: What’s New?

The new European guidelines on NON-ST-segment elevation acute coronary syndromes (NSTE ACS) were presented virtually during the...

ESC 2020 | Ticagrelor Might Increase Bleeding and Mortality in the Elderly

Ticagrelor compared against clopidogrel produces more bleeding and also more deaths in patients over 80 recently undergoing...

ESC 2020 | Acute Myocardial Infarction and Anemia: Are Transfusions Necessary?

In anemic patients undergoing acute myocardial infarction, a restrictive transfusion strategy is as safe as a more...

Can Aspirin Use Be Interrupted After Angioplasty?

Aspirin discontinuation 1 to 3 months after angioplasty with continued P2Y12 inhibitor therapy reduces the bleeding risk without...

LATAM: Information on the Impact of the Pandemic with a Focus on MI

There are several studies from all corners of the world (China, Europe, USA) presenting data on the...

Early Activation to Speed-Up Treatment of Infarcted Patients

Cath lab activation—and everything that entails—within 20 minutes was associated with the target of performing primary angioplasty in...

Is Medical Treatment Better at Lowering Bleeding-Caused Mortality than Angioplasty?

Post-discharge bleeding in patients admitted for acute coronary syndrome (ACS) is linked to higher all-cause mortality. However,...